Glucotrack, Inc. (NASDAQ:GCTK) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on February 09, 2026. The Healthcare company's proxy…
Glucotrack, Inc. (NASDAQ:GCTK) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on February 09, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Glucotrack, Inc.'s stock currently trades at $1.75 with a market capitalization of $3.3M.
Current market data
NASDAQ · GCTK
$3.23
Up: +$0.09 · +2.87%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
sec_filing ·
sec_filing ·
sec_filing ·
sec_filing ·
